BMT Tandem "Scientific" Meeting
Ballroom E-H (Salt Palace Convention Center)
Chairs:
Bronwen Shaw
and
Steve Spellman, MBS
Summary:
Abstracts: #2478, 2725, 2323, 2623, 2564, 2264
Nonmyeloablative Conditioning Regimen Plus A2AR Agonist Oral Administration Promote Engraftment On Allogeneic Bone Marrow Transplantation Mouse Model
Kyu Lee Han, Ph. D., National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Stephenie V. M. Thomas, National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Ok Jae Koo, Ph. D., National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Sherry M. Koontz, National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Harry L. Malech, MD, National Institute of Allergy and Infectious Diseases, National Institutes of Health;
Elizabeth Kang, MD, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Results of a Prospective Multi-Center Myeloablative Double-Unit Cord Blood Transplantation Trial in Adult Patients with Acute Leukemia and Myelodysplasia (submitted on behalf of the RCI BMT 05-DCB Protocol Team)
Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center;
Mingwei Fei, MS, Medical College of Wisconsin;
Waleska Perez, MPH, Medical College of WI;
Alexia Adams, CIBMTR Minneapolis, National Marrow Donor Program;
Dennis L. Confer, MD, CIBMTR/National Marrow Donor Program;
Mary M. Horowitz, MD, MS, CIBMTR/Medical College of Wisconsin;
Willis H. Navarro, MD, University of California, San Francisco;
Marcie Tomblyn, MD, MS, H. Lee Moffitt Cancer Center
Donor-Recipient HLA-Matching of Unrelated Cord Blood (CB) Units At High-Resolution Reveals High Degrees of HLA-Mismatch and Alters Graft Selection
Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center;
Doris Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Anne Marie Gonzales, BS, Memorial Sloan-Kettering Cancer Center;
Courtney Byam, BS, Memorial Sloan-Kettering Cancer Center;
Rosanna Ferrante, BA, Memorial Sloan-Kettering Cancer Center;
Melissa Sideroff, BA, Memorial Sloan-Kettering Cancer Center;
Deborah Wells, MA, Memorial Sloan-Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, Memorial Sloan-Kettering Cancer Center;
Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center
The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy
Craig Kollman, PhD, Jaeb Center for Health Research;
John P Klein, PhD, Medical College of Wisconsin;
Stephen R Spellman, MBS, CIBMTR;
Anna Hassebroek, MPH, CIBMTR-Minneapolis;
Dennis L. Confer, MD, CIBMTR/National Marrow Donor Program;
Marcelo Fernandez-Vina, PhD, D(ABHI), Stanford University Medical School;
Robert Hartzman, MD, Naval Medical Research Center;
Carolyn Katovich Hurley, PhD, Georgetown University;
Martin Maiers, National Marrow Donor Program;
Carlheinz R. Mueller, MD, ZKRD - Zentrales Knochenmarkspender-Register Deutschland ;
Michelle Setterholm, National Marrow Donor Program;
Ann Woolfrey, MD, Fred Hutchinson Cancer Research Center;
Neng Yu, MD, American Red Cross;
Mary Eapen, MD, MS, Medical College of Wisconsin
Higher Infused CD34+ Dose Positively Influence Platelet Recovery After Cord Blood Transplantation
Filippo Milano, MD, PhD, Fred Hutchinson Cancer Research Center;
Katherine A. Guthrie, PhD, Fred Hutchinson Cancer Research Center;
Rachel Salit, MD, University of Washington;
Terry Gernsheimer, Puget Sound Blood Center;
Colleen Delaney, MD, MSc, Fred Hutchinson Cancer Research Center
Graft-Specific HLA-Antibodies Do Not Influence Unit Dominance and Do Not Prevent High Rates of Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood (CB) Transplantation
Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center;
Jonathan Barone, BS, American Red Cross;
Susan Hsu, PhD, American Red Cross;
Courtney Byam, BS, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Doris Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, Memorial Sloan-Kettering Cancer Center;
Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center
![[Visit Client Website]](images/banner.gif)